预测膜性肾小球肾炎的病情进展 - Suppr

Suppr

超能文献

Predicting progression in membranous glomerulonephritis.

作者信息

Cattran D C, Pei Y, Greenwood C

机构信息

Toronto Hospital, University of Toronto, Canada.

出版信息

Nephrol Dial Transplant. 1992;7 Suppl 1:48-52.

PMID:1337182

Abstract

摘要

相似文献

Predicting progression in membranous glomerulonephritis.

Nephrol Dial Transplant. 1992;7 Suppl 1:48-52.

[The late results of treating membranous glomerulonephritis].

Vutr Boles. 1990;29(3):53-60.

[Membranous glomerulonephritis].

Srp Arh Celok Lek. 1996;124 Suppl 1:18-25.

Remission of proteinuria with treatment of Actinomyces infection: eradicating a cause of secondary membranous glomerulopathy suppresses nephrotic syndrome.

Nephrol Dial Transplant. 2009 Oct;24(10):3236-9. doi: 10.1093/ndt/gfp284. Epub 2009 Jun 10.

The natural history of the non-nephrotic membranous nephropathy patient.

Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.

Membranous glomerulonephritis and the nephrotic syndrome in a patient with Landry-Guillain-Barré-Strohl syndrome.

West Indian Med J. 1989 Mar;38(1):51-3.

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.

Am J Kidney Dis. 2005 Dec;46(6):1012-29. doi: 10.1053/j.ajkd.2005.08.020.

Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.

Nephrol Dial Transplant. 2008 Aug;23(8):2546-51. doi: 10.1093/ndt/gfn007. Epub 2008 Feb 28.

The more things change..

Am J Kidney Dis. 2001 Aug;38(2):406-8. doi: 10.1053/ajkd.2001.27007.

Kimura disease: a case report and review of the Chinese literature.

Nephron Clin Pract. 2009;111(1):c55-61. doi: 10.1159/000178980. Epub 2008 Dec 3.

引用本文的文献

Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.

Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20230871. doi: 10.1590/1806-9282.20230871. eCollection 2024.

Membranous Nephropathy With Crescents.

Kidney Int Rep. 2020 Jan 30;5(4):537-541. doi: 10.1016/j.ekir.2020.01.010. eCollection 2020 Apr.

Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.

BMC Nephrol. 2019 Dec 2;20(1):442. doi: 10.1186/s12882-019-1637-y.

Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.

BMC Nephrol. 2017 Feb 1;18(1):44. doi: 10.1186/s12882-017-0459-z.

Patients with primary membranous nephropathy are at high risk of cardiovascular events.

Kidney Int. 2016 May;89(5):1111-1118. doi: 10.1016/j.kint.2015.12.041. Epub 2016 Feb 26.

Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.

PLoS One. 2015 Apr 15;10(4):e0116700. doi: 10.1371/journal.pone.0116700. eCollection 2015.

Low- and high-molecular-weight urinary proteins as predictors of response to rituximab in patients with membranous nephropathy: a prospective study.

Nephrol Dial Transplant. 2013 Jan;28(1):137-46. doi: 10.1093/ndt/gfs379. Epub 2012 Sep 17.

Controversies in the treatment of idiopathic membranous nephropathy.

Nat Rev Nephrol. 2009 Aug;5(8):469-79. doi: 10.1038/nrneph.2009.101. Epub 2009 Jul 7.

[Membranous glomerulonephritis].

Internist (Berl). 2003 Sep;44(9):1120-30. doi: 10.1007/s00108-003-1022-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验